Clinical Trial Update: Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cetuximab in Menetrier disease patients at high risk of developing stomach cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Menetrier Disease
• Precancerous Condition

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Vanderbilt University | Conditions: Gastric Cancer, Precancerous Condition | Phase 1 | Status: COMPLETED